These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8991238)

  • 61. Seroprevalence of Lyme disease in Eastern Slovakia.
    Bušová A; Dorko E; Rimárová K; Diabelková J; Rovenská T; Feketeová E; Bereš M; Čellár R; Baranová Z; Kampe T; Benhatchi K
    Cent Eur J Public Health; 2018 Dec; 26 Suppl():S67-S71. PubMed ID: 30817877
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lyme borreliosis--problems of serological diagnosis.
    Hofmann H
    Infection; 1996; 24(6):470-2. PubMed ID: 9007597
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Epidemiological aspects of neurological complications of Lyme borreliosis in Switzerland. A case-control study].
    Altpeter ES; Meier C
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):22-6. PubMed ID: 1594902
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The incidence of Lyme arthritis and of antibodies to Borrelia burgdorferi in rheumatology patients in an endemic area].
    Lesniak OM; Sokolova ZI; Laĭkovskaia EE; Riabitseva OF
    Ter Arkh; 1994; 66(5):45-7. PubMed ID: 7940338
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Results of etiologic diagnosis in clinical syndrome consistent with acute and chronic borreliosis].
    Persecă T; Feder A; Molnar GB
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):496-501. PubMed ID: 19295026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Are seroprevalence studies useful in Lyme disease?].
    Díaz-Míguez D; Fernández-Fernández F; Sesma P; Rodríguez-Mayo MD
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):460-1. PubMed ID: 8260522
    [No Abstract]   [Full Text] [Related]  

  • 68. Lyme disease.
    Cunha BA
    Compr Ther; 1993; 19(4):135. PubMed ID: 8261766
    [No Abstract]   [Full Text] [Related]  

  • 69. Significant variations in the seroprevalence of C6 ELISA antibodies in a highly endemic area for Lyme borreliosis: evaluation of age, sex and seasonal differences.
    Johansson M; Manfredsson L; Wistedt A; Serrander L; Tjernberg I
    APMIS; 2017 May; 125(5):476-481. PubMed ID: 28225145
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Borrelia burgdorferi infection in UK horses.
    Carter SD; May C; Barnes A; Bennett D
    Equine Vet J; 1994 May; 26(3):187-90. PubMed ID: 8542836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The epidemiology of Borrelia burgdorferi infections. A pilot study from the Männedorf area].
    Satz N; Ackermann R; Gern L; Aeschlimann A; Ott A; Knoblauch M
    Schweiz Med Wochenschr; 1988 Mar; 118(12):422-6. PubMed ID: 3375784
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lyme borreliosis in central France: a sero-epidemiologic examination involving hunters.
    Christiann F; Rayet P; Patey O; Ngueodjibaye DB; Theron-le Gargasson JF; Lafaix C
    Eur J Epidemiol; 1997 Oct; 13(7):855. PubMed ID: 9384279
    [No Abstract]   [Full Text] [Related]  

  • 73. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.
    Mathiesen MJ; Christiansen M; Hansen K; Holm A; Asbrink E; Theisen M
    J Clin Microbiol; 1998 Dec; 36(12):3474-9. PubMed ID: 9817857
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of seroprevalence and risk factors in Lyme disease.
    Bušová A; Dorko E; Feketeová E; Rimárová K; Diabelková J; Rovenská T; Csank T
    Cent Eur J Public Health; 2018 Dec; 26 Suppl():S61-S66. PubMed ID: 30817876
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
    Breier P; Klade H; Stanek G; Poitschek C; Kirnbauer R; Dorda W; Aberer E
    Br J Dermatol; 1996 Feb; 134(2):285-91. PubMed ID: 8746343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Epidemiologic situation of Lyme borreliosis in Europe].
    Flisiak R; Zabicka J
    Przegl Epidemiol; 1995; 49(4):375-9. PubMed ID: 8868195
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ELISA screening for Lyme disease in children with chronic arthritis.
    Hammouda NA; Hegazy IH; el-Sawy EH
    J Egypt Soc Parasitol; 1995 Aug; 25(2):525-33. PubMed ID: 7665949
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serological survey for Borrelia burgdorferi infection in cattle in southern Hokkaido.
    Takahashi K; Isogai E; Isogai H; Takagi T; Sasaki K; Fujii N; Kimura K
    J Vet Med Sci; 1993 Dec; 55(6):921-4. PubMed ID: 8117816
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term study of Lyme borreliosis in a highly endemic area in Sweden.
    Berglund J; Eitrem R; Norrby SR
    Scand J Infect Dis; 1996; 28(5):473-8. PubMed ID: 8953677
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Population-based Borrelia burgdorferi sensu lato seroprevalence and associated risk factors in Finland.
    van Beek J; Sajanti E; Helve O; Ollgren J; Virtanen MJ; Rissanen H; Lyytikäinen O; Hytönen J; Sane J
    Ticks Tick Borne Dis; 2018 Feb; 9(2):275-280. PubMed ID: 29153461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.